These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11087791)

  • 1. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease.
    Chapman T; McKeel DW; Morris JC
    Neurology; 2000 Nov; 55(9):1396-7. PubMed ID: 11087791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease.
    Aksamit AJ; Preissner CM; Homburger HA
    Neurology; 2001 Aug; 57(4):728-30. PubMed ID: 11524493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14-3-3 protein in the CSF of patients with rapidly progressive dementia.
    Huang N; Marie SK; Livramento JA; Chammas R; Nitrini R
    Neurology; 2003 Aug; 61(3):354-7. PubMed ID: 12913197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease.
    Green AJ
    Biochem Soc Trans; 2002 Aug; 30(4):382-6. PubMed ID: 12196099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI.
    Donahue JE; Hanna PA; Hariharan S
    Neurol Sci; 2004 Feb; 24(6):411-3. PubMed ID: 14767688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease.
    Green AJ; Thompson EJ; Stewart GE; Zeidler M; McKenzie JM; MacLeod MA; Ironside JW; Will RG; Knight RS
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):744-8. PubMed ID: 11385008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-3-3 Protein isoforms and atypical patterns of the 14-3-3 assay in the diagnosis of Creutzfeldt-Jakob disease.
    Sánchez-Valle R; Saiz A; Graus F
    Neurosci Lett; 2002 Mar; 320(1-2):69-72. PubMed ID: 11849766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of 14-3-3 protein levels in cerebrospinal fluid from Creutzfeldt-Jakob patients by a highly sensitive capture assay.
    Peoc'h K; Schröder HC; Laplanche J; Ramljak S; Müller WE
    Neurosci Lett; 2001 Apr; 301(3):167-70. PubMed ID: 11257424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease.
    Green AJ; Knight RS; Macleod MA; Lowman A; Will RG
    Neurology; 2001 Apr; 56(7):986-7. PubMed ID: 11294951
    [No Abstract]   [Full Text] [Related]  

  • 10. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.
    Geschwind MD; Martindale J; Miller D; DeArmond SJ; Uyehara-Lock J; Gaskin D; Kramer JH; Barbaro NM; Miller BL
    Arch Neurol; 2003 Jun; 60(6):813-6. PubMed ID: 12810484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.
    Lanska DJ
    Neurology; 2001 May; 56(10):1422-3. PubMed ID: 11376210
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased detection of 14-3-3 protein in cerebrospinal fluid in Sporadic Creutzfeldt-Jakob Disease during the disease course.
    Giraud P; Biacabe AG; Chazot G; Later R; Joyeux O; Moene Y; Perret-Liaudet A
    Eur Neurol; 2002; 48(4):218-21. PubMed ID: 12422071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid.
    Collins S; Boyd A; Fletcher A; Gonzales M; McLean CA; Byron K; Masters CL
    J Clin Neurosci; 2000 May; 7(3):203-8. PubMed ID: 10833616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted MRI in Creutzfeldt-Jakob disease: a better diagnostic marker than CSF protein 14-3-3?
    Mendez OE; Shang J; Jungreis CA; Kaufer DI
    J Neuroimaging; 2003 Apr; 13(2):147-51. PubMed ID: 12722497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF detection of the 14-3-3 protein in unselected patients with dementia.
    Burkhard PR; Sanchez JC; Landis T; Hochstrasser DF
    Neurology; 2001 Jun; 56(11):1528-33. PubMed ID: 11402110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease].
    Sáiz A; Marín C; Tolosa E; Graus F
    Neurologia; 1998; 13(7):324-8. PubMed ID: 9810794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extreme loss of neurons in sporadic Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid.
    Tabaka J; Nowacki P; Stankiewicz J; Wierzba-Bobrowicz T
    Folia Neuropathol; 2003; 41(1):47-50. PubMed ID: 12862396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease].
    Bernheimer H; Gatterbauer B; Radbauer C; Budka H
    Wien Med Wochenschr; 1998; 148(4):96-100. PubMed ID: 9611349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients.
    Van Everbroeck B; Dobbeleir I; De Waele M; De Deyn P; Martin JJ; Cras P
    J Neurol; 2004 Mar; 251(3):298-304. PubMed ID: 15015009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease.
    Otto M; Wiltfang J; Cepek L; Neumann M; Mollenhauer B; Steinacker P; Ciesielczyk B; Schulz-Schaeffer W; Kretzschmar HA; Poser S
    Neurology; 2002 Jan; 58(2):192-7. PubMed ID: 11805244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.